Next Generation NanoMAb® Technology Based on a wide array of nanobody libraries from immunized camelidFocusing on new antigen targets Developing nanobody-based cancer therapeutics with high affinity and low immunogenicityFrom bispecific nanobodies to genetic ally conjugated Nanotoxin®High-throughput cell line developmentTargeted integration into hot-spot chromatin structureMulti-targeting with stable protein structure